Endocrine and Metabolic Systems Flashcards
(39 cards)
The hypothalamus controls release of pituitary hormones including
- Corticotropin-releasing hormone (CRH)
- Thyrotropin-releasing hormone (TRH)
- Growth hormone-releasing hormone (GHRH)
- Somatostatin
The anterior pituitary gland controls the release of which hormones
- Growth hormone (GH)
- Adrenocorticotropic hormone (ACTH)
- Follicle-stimulating hormone (FSH)
- Luteinizing hormone (LH)
- Prolactin
The posterior pituitary gland stores and releases which hormones
- Antidiuretic hormone (ADH)
- Oxytocin
S/S of diabetes mellitus
- Acute: excessive weight thirst/urination, fatigue, weight loss, vision problems, HA/dizziness
- Chronic: neuropathy, retinopathy, nephropathy, atherosclerosis (small and large vessels)
S/S of hyperthyroidism
- Graves disease
- Females age 20-40
- Weight loss, fatigue, excessive sweating, diarrhea, palpitations, hyperreflexia, tremor, & exophthalmos
S/S of hypothyroidism
- Females age 30-60
- Weight gain, hair loss, fatigue, bradycardia, constipation, anemia, carpal tunnel syndrome, fibromyalgia, depression
S/S of hyperparathyroidism
- Females age >60
- Bone decalcification
- Weakness/fatigue
- Joint hyper mobility
- Peptic ulcers, pancreatitis
- Renal calculi, renal failure
- CNS: memory, depression, personality changes
S/S of hypoparathyroidism
- Muscle weakness, pain, and tetany
- Trousseau sign (carpal spasm)
- Chvostek sign (facial spasm)
- Seizures
S/S of hypercortisolism
- Cushing’s syndrome/disease: Moon shaped face, dorsacervical fat pad, truncal obesity, slender limbs, thinning of the skin-striae, hair loss, bruise easily
S/S of adrenal insufficiency
- Addison’s disease
- Cortisol Sxs: personality changes, bronze skin pigmentation, hypoglycemia with associated symptoms, susceptible to infections
- Aldosterone Sxs: increased Na excretion-dehydration, hypotension, diarrhea, abdominal pain
The adrenal cortex controls the release of
- Mineral corticosteroids (aldosterone)
- Glucocorticoids (cortisol)
- Adrenal androgens (dehydroepiandrosterone - DHEA)
- Androstenedione
The adrenal medulla controls the release of
- Epinephrine
- Norepinephrine
The thyroid controls the release of
- Triiodothyronine
- Thyroxine
- Thyroid C cells control release of calcitonin
The pancreatic islet cells control the release of
- Insulin
- Glucagons
- Somatostatin
What is the function of insulin
- Allows uptake of glucose from the bloodstream
- Suppresses hepatic glucose production, lowering plasma glucose levels
- Secreted by beta cells
What is the function of glucagon
- Stimulates hepatic glucose production to raise glucose levels
- Secreted by alpha cells
What is the function of amylin
- Modulates rate of nutrient delivery
- Suppresses release of glucagon
- Secreted by beta cells
What is the function of somatostatin
- Acts locally to depress secretion of both insulin and glycogen
- Decreases motility of stomach, duodenum, and gallbladder
- Decreases secretion and absorption of GI tract
- Secreted by delta cells
Diagnosis of metabolic syndrome (syndrome X) requires the presence of 3 or more of the following risk factors
- Abdominal obesity: men ≥40inch and women ≥35inch
- High triglyceride level: ≥150 mg/dl or using a cholesterol medicine
- Cholesterol: low HDL (men <40 and women < 50) or using cholesterol medicine
- High BP: systolic ≥135 and/or diastolic ≥85
- Blood sugar: fasting plasma glucose level ≥100 mg/dl
Characteristics of Type 1 diabetes
- Decrease in size and number of islet cells resulting in absolute deficiency in insulin secretion
- Initially occurs in children and young adults, often with abrupt onset of symptoms around the age of puberty
- Insulin dependent: requires insulin delivery
- Prone to ketoacidosis: presence of ketone bodies in the urine
Characteristics of Type 2 diabetes
- Results from inadequate utilization of insulin (insulin resistance) and progressive beta cell dysfunction
- Individual is not prone to ketoacidosis (may form ketones with stress)
- Progressive disease caused by insulin resistance in muscle and adipose tissue, progressive decline in pancreatic insulin production, excessive hepatic glucagon secretion, and inappropriate glucagon secretion
Diagnostic criteria for DM
- Sx of diabetes plus casual plasma glucose concentration ≥200 mg/dl (causal defined as non fasting)
- Fasting plasma glucose ≥126 mg/dl
- 2-hour post load glucose ≥200 mg/dl (during an oral glucose tolerance test)
- A1c test measures average blood glucose for the past 2-3mo: normal = <5.7%; pre diabetes = 5.7%-6.4%; diabetes = ≥6.5%
Outcomes of regular exercise on diabetes
- Improved glucose tolerance
- Increased insulin sensitivity
- Decreased glycosylated hemoglobin
- Decreased insulin requirements
- BP reduction
Cardiovascular guidelines for exercise testing in patients with diabetes
- 50-80% of max oxygen uptake (VO2max) or HRR corresponding to RPE of 12-16 on the 6-20 Borg scale
- 3-7 days/week
- 20-60 minutes
- Rhythmic, large muscle activity: biking, treadmill walking, overground walking